Circulating cytokine profiles in leprosy patients

Leprosy Review

Volumn 78, Issue 3, 2007, Pages 223-230

  Belgaumkar, Vasudha A ^a,b   Gokhale, Neeta R ^a   Mahajan, Pradeep M ^a   Bharadwaj, Renu ^a   Pandit, Dakshayani P ^a   Deshpande, Shantanu ^a  

^a B J MEDICAL COLLEGE   (India)

^b B J Medical College ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6;

ARTICLE; CONTROLLED STUDY; HUMAN; LEPROMATOUS LEPROSY; LEPROSY; MAJOR CLINICAL STUDY; MYCOBACTERIUM LEPRAE; PROTEIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; HOSPITALIZATION; IMMUNOLOGY; PATHOLOGY;

CASE-CONTROL STUDIES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; LEPROSY; MYCOBACTERIUM LEPRAE; SEVERITY OF ILLNESS INDEX;

EID: 38449091743     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Harboe M. Overview of host parasite relations. In: Hastings RC and Opromolla DVA (eds). Leprosy, 2nd edn. Churchill Livingstone, New York, 1994, pp. 87-112.
2. Volc-Platzer B, Stemberger H, Luger T et al. Defective intralesional INF gamma activity in patients with lepromatous leprosy. Clin Exp Immunol, 1988; 71: 235-240.
3. Arnoldi J, Gerdes J, Frad HD. Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy. Am J Pathol, 1990; 137(7): 49-753.
4. Mossman TR, Cherwinski H, Bond MW et al. Two types of murine helper T cell clones. J Immunol, 1986; 136: 2348-2357.
5. Janeway CA, Carding S, Jones B et al. CD 4 T cells: specificity and function. Immunol Rev, 1988; 101: 39-80.
6. Ramos T, Quintana IZ, Appelberg R. T helper cell subpopulations and the immune spectrum of leprosy. Int J Lepr Other Mycobac Dis, 1989; 57: 73-81.
7. Yemuri N. Cytokine patterns using molecular tools. Ind J Lepr, 2000; 72: 175-185.
8. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five group system. Int J Lepr Other Mycobac Dis, 1966; 34: 255-273.
9. Indian Association of Leprologists approved classification. Lepr India, 1982; 54: 22-32.
10. Mossmann TR, Coffman RL. TH1 and TH2 cells. Annu Rev Immunol, 1989; 7: 145-173.
11. Ochoa MT, Valderrama L, Ochoa A, Zea A, Escobar CE, Moreno LH, Falabella R. Lepromatous and Tuberculoid leprosy: clinical presentations and cytokine Responses. Int J Dermatol, 1996; 35(11): 786-790.
12. O'Garra A. Interleukin and the immune system. Lancet, 1989; i: 943-947.
13. Yamamura M, Uyemura K, Deans RJ et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science, 1991; 254: 277-279.
14. Barnes PF, Abrams JS, Lu S et al. Patterns of cytokine production by Mycobacterium-reactive human T cell clones. Infect Immun, 1993; 61: 197-201.
15. Mutis T, Kraakman EM, Cornalise YE et al. Analysis of cytokine production by Mycobacterium reactive T cells. J Immunol, 1993; 150: 4641-4651.
16. Howe RC, Wondimu A, Demissee A et al. Functional heterogeneity among CD4 + T cells from blood and skin lesions of leprosy patients: Identification of T Cell clones distinct from Th0, Th1 & Th2. Immunology, 1995; 84: 585-594.
17. Misra N, Murtaza A, Walker et al. Cytokine profile of circulating T cells of leprosy patients reflects both indeterminate and polarized T helper subsets: T helper phenotype is stable and uninfluenced by related antigens of M leprae. Immunology, 1995; 86: 97-103.
18. Nath I, Murtuza A, Singh S. The role of cytokines in leprosy. In: T cell subsets and cytokines interplay in infectious diseases. 1996. Basel, Karger,189-200.
19. Pfaltzgraff RE and Ramu G. Clinical Leprosy. In: Hastings RC and Opromolla DVA (eds). Leprosy, 2nd edn. Churchill Livingstone, Edinburgh, New York, 1994, pp. 265.
20. Pannikar VK, Arunthathi S, Chacko CJ, Fritchi EP. A Clinicopathological study of primary neuritic leprosy. Lepr India, 1983; 55: 212-221.
21. Uplekar MW, Antia NH. Clinical and histopathological observations on pure neuritic leprosy. Ind J Lepr, 1986; 58: 513-521.
22. Kaur G, Girdhar BK, Girdhar A, Malaviya GN et al. A clinical, immunological and histological study of neuritic leprosy patients. Int J Lepr Other Mycobact Dis, 1991; 59: 385-391.
23. Moubasher AA, Kamel NA, Zedan H, Raheem DA. Cytokines in Leprosy I-Serum cytokine profile in leprosy. Int J Dermatol, 1998; 37: 733.
24. Sengupta U. Immunopathology of leprosy-Current status. Ind J Lepr, 2000; 72: 381-391.
25. Kaplan G, Nusrat A, Sarno EN et al. Cellular responses to the intradermal injection of recombinant human interferon gamma in lepromatous leprosy patients. Am J Pathol, 1987; 128: 345-353.
26. Sivasai KSR, Prasad HK, Misra RS et al. Effect of recombinant INF gamma administration on lesional monocyte/macophages in lepromatous leprosy patients. Int J Lepr Other Mycobact Dis, 1993; 61: 259-269.
27. Sieling PA, Modlin RL. Cytokine patterns at the site of mycobacterial infection. Immunobiol, 1994; 191: 378-387.
28. Farrar MA, Screiber RD. The molecular cell biology of interferon gamma and its receptor. Ann Rev Immunol, 1993; 11: 571-611.
29. Frei K, Nodal D, Pfister HW et al. Listeria meningitis: identification of a CSF Inhibitor of macrophage listericidal function as IL 10. J Exp Med, 1993; 178: 1255-1261.
30. Seghal PB. IL 6. Molecular pathophysiology. J Invest Dermatol, 1990; 94: 2S-6S.
31. Moraes, Sarno, Almeida, Saraiva, Nery, Martins, Sampaio. Cytoplasmic mRNA expression in leprosy: a possible role for INF gamma and IL 12 in reactions (RR & ENL). Scand J Immunol, 1999; 50: 541.
32. Faber WR, Iyer AM, Fajardo TT, Dekker T, Villahermosa LG, Abalos RM, Das PK. Serial measurement of serum cytokines,cytokine receptors and neopterin in Leprosy patients with reversal reactions. Lepr Rev, 2004; 75: 274-281.
33. Lima MCBC, Pereira GMB, Rumjanek FD et al. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy. Scan J Immunol, 2000; 51: 419-428.